Semaglutide use in people with obesity and type 2 diabetes from real-world utilization data: an analysis of the all of US program
Animal Study Suggests How Drugs Could Curb Alcohol Cravings In the study, researchers in Sweden tested tirzepatide, a medication that activates both GLP-1 and GIP receptors , in rats that had developed a strong habit of drinking alcohol
Gingivitis was observed in 1% of adult patients receiving topiramate during add-on epilepsy trials
Ozempic (semaglutide) is well-known for its weight loss benefits, as well as its ability to improve the quality of life for individuals living with type 2 diabetes
Several factors may indicate its time to consider discontinuation: Stable health improvements: Some individuals achieve significant weight loss, improved glycemic control, or normalized blood pressure and lipid levels, which may reduce the clinical need for continued medication
GLP-1 agonists, by design, improve gut function creating a positive cascade that supports clearer thinking and emotional regulation